MARKET

RANI

RANI

Rani Therapeutics Holdings, Inc.
NASDAQ
1.220
+0.120
+10.91%
After Hours: 1.200 -0.02 -1.64% 19:16 02/06 EST
OPEN
1.120
PREV CLOSE
1.100
HIGH
1.270
LOW
1.110
VOLUME
973.55K
TURNOVER
--
52 WEEK HIGH
3.870
52 WEEK LOW
0.3870
MARKET CAP
148.26M
P/E (TTM)
-1.5433
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RANI last week (0126-0130)?
Weekly Report · 6d ago
Rani Therapeutics Names Alireza Javadi Chief Technical Officer
NASDAQ · 01/28 12:32
Rani Therapeutics Promotes Alireza Javadi to Chief Technical Officer
Reuters · 01/28 12:01
RANI THERAPEUTICS ANNOUNCES THE PROMOTION OF ALIREZA JAVADI, PH.D. TO CHIEF TECHNICAL OFFICER
Reuters · 01/28 12:00
Press Release: Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
Dow Jones · 01/28 12:00
Rani Therapeutics Unveils Oral Biologics Platform Targeting Injection-Free Treatments
Reuters · 01/27 16:23
Weekly Report: what happened at RANI last week (0119-0123)?
Weekly Report · 01/26 10:37
Largest borrow rate increases among liquid names
TipRanks · 01/23 13:45
More
About RANI
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics and drugs. The Company has developed the RaniPill capsule, which is a proprietary and patented platform technology, intended to replace subcutaneous injection or intravenous infusion of biologics and drugs with oral dosing. The RaniPill capsule is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. It has two configurations of the platform: the RaniPill GO and the RaniPill HC. The RaniPill GO is designed to deliver up to a 3 mg dose of drug in microtablet form with high bioavailability. It is also developing a high-capacity version of the RaniPill capsule known as the RaniPill HC. Its product candidate pipeline includes obesity programs (RT-114 and RT-116), immunology programs (RT-105 and RT-111) and endocrinology programs (RT-102 and RT-110).

Webull offers Rani Therapeutics Holdings Inc stock information, including NASDAQ: RANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RANI stock methods without spending real money on the virtual paper trading platform.